Brief: Ceapro Receives Research License From Health Canada Controlled Substances And Cannabis Branch
14/02/2020 13:25
Feb 14 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO INC. RECEIVES RESEARCH LICENSE FROM HEALTH CANADA
CONTROLLED SUBSTANCES AND CANNABIS BRANCH
Source text for Eikon: ID:nGNX5HP2p3
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases